WallStreetZenWallStreetZen

NASDAQ: RGLS
Regulus Therapeutics Inc Earnings & Revenue

RGLS past revenue growth

How has RGLS's revenue growth performed historically?
Company
N/A
Industry
169.3%
Market
17.86%
RGLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RGLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RGLS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$30.0M
Current Profit Margin
0%

RGLS Return on Equity

Current Company
-109.2%
Current Industry
-63.4%
Current Market
188%
RGLS's Return on Equity (-109.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RGLS announces earnings.

RGLS Return on Assets

Current Company
-80.6%
Current Industry
3.2%
RGLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RGLS Return on Capital Employed

Current Company
-132.33%
Current Industry
19.9%
RGLS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGLS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RGLS$0.00-$29.21M-$30.04M-100.00%N/A
OBIO$2.76M-$48.20M-$49.12M-80.21%N/A
ACET$0.00-$133.69M-$142.66M-100.00%N/A
IPHA$67.00M-$700.00k-$8.23M-8.70%N/A
PRQR$10.35M-$26.33M-$30.56M+9.83%N/A

RGLS earnings dates

Next earnings date
May 9, 2024

Regulus Therapeutics Earnings & Revenue FAQ

What were RGLS's earnings last quarter?

On Invalid Date, Regulus Therapeutics (NASDAQ: RGLS) reported Q4 2023 earnings per share (EPS) of -$0.39, up 2.5% year over year. Total Regulus Therapeutics earnings for the quarter were -$8.06 million. In the same quarter last year, Regulus Therapeutics's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Regulus Therapeutics stock.

What was RGLS's earnings growth in the past year?

As of Q1 2024, Regulus Therapeutics's earnings has grown year over year. Regulus Therapeutics's earnings in the past year totalled -$30.04 million.

What is RGLS's earnings date?

Regulus Therapeutics's earnings date is Invalid Date. Add RGLS to your watchlist to be reminded of RGLS's next earnings announcement.

What was RGLS's revenue last quarter?

On Invalid Date, Regulus Therapeutics (NASDAQ: RGLS) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Regulus Therapeutics's revenue was $0.00.

What was RGLS's revenue growth in the past year?

As of Q1 2024, Regulus Therapeutics's revenue has grown null year over year. Regulus Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.